Longeveron Inc.

LGVNNasdaq· Pharmaceutical Preparations

Price History

Revenue

$1.2M

▼ 49.9% YoY

Net Income

-$22.7M

▼ 42.1% YoY

EPS

$-1.29

▲ 50.8% YoY

Cash

$4.7M

▼ 75.8% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.